Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-02-21A Four-Week Double Blind Multicenter Study Comparing The Efficacy And Safety Of Ziprasidone To Aripiprazole In Subjects With Schizophrenia Or Schizoaffective Disorder Needing Inpatient Care
-
CLINICAL_TRIALS study record update · 2021-02-21Ziprasidone Intramuscular/Oral In The Treatment Of Acute Exacerbation Of Schizophrenia Or Schizoaffective Disorder: A Six-Week Open Administration Study
-
CLINICAL_TRIALS study record update · 2021-02-21A Multi-Center Study to Examine The Clinical Effects of Cross Titration of Antipsychotics With Ziprasidone in Subjects With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2021-02-21Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia: A Six Months, Double Blind Randomized, Parallel Group Study.
-
CLINICAL_TRIALS study record update · 2021-02-21Efficacy And Safety Of Ziprasidone In Acute Exacerbation Of Schizophrenia Or Schizoaffective Disorder, Including Patients With A Diagnosis Of Recent Onset
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-02-21Open Extension Study Evaluating the Long-term Efficacy, Safety, and Tolerability of Oral Ziprasidone in the Treatment of Resistant/Intolerant Schizophrenic Patients Who Have Acutely Responded to Ziprasidone in the Mozart Study
-
CLINICAL_TRIALS study record update · 2021-02-21An Open, Multicenter, Non-Comparative Study To Assess The Efficacy And Tolerability Of Intramuscular Ziprasidone Followed By Oral Ziprasidone In Patients With Acute Psychosis
-
CLINICAL_TRIALS study record update · 2021-02-21Double Blind, Double-Dummy Multicenter, Parallel Group Comparison Of The Efficacy And The Tolerability Of Ziprasidone Vs. Clozapine In Schizophrenic Patients Who Are Refractory And/Or Intolerant To Antipsychotic Therapy
-
CLINICAL_TRIALS study record update · 2021-02-21Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (CRESSOB)
-
CLINICAL_TRIALS study record update · 2021-02-21Tolerability, Safety, And Efficacy Of Ziprasidone (80 - 160 Mg/D) Versus Olanzapine (10 - 20 Mg/D), Risperidone (4 - 8 Mg/D) Or Quetiapine (300 - 750 Mg/D) In Pretreated Patients With Schizophrenia, Schizoaffective Disorder Or Schizophreniform Disorders - A 12-Week Open-Label, Multicenter Clinical Trial.
-
CLINICAL_TRIALS study record update · 2021-02-17Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study
-
CLINICAL_TRIALS study record update · 2021-02-15A Randomized, Open Label, Parallel Group, Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
-
CLINICAL_TRIALS study record update · 2021-02-10Multi-site Communication Deficits Underlying Cognitive Dysfunction in the Prodromal Phase and First Episode of Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-10Cognitive Remediation of Executive Dysfunction - Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-09A Phase IIb, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Basmisanil (RO5186582) as Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia Treated With Antipsychotics
-
CLINICAL_TRIALS study record update · 2021-02-08Compensatory Cognitive Training in Clinical High Risk Latino Youth
-
CLINICAL_TRIALS study record update · 2021-02-08Connectomics in Psychiatric Classification
-
CLINICAL_TRIALS study record update · 2021-02-08Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan
-
CLINICAL_TRIALS study record update · 2021-02-05The Effect of Salutogenic Approach Based Interview on Sense of Coherence and Psychological Resistance of People With Schizophrenia: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-02-05Metformin and Lorcaserin for Weight Loss in Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-01-27Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2021-01-25ClinicalTrials.gov study NCT02220712
-
CLINICAL_TRIALS study record update · 2021-01-22A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2021-01-19A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics
-
CLINICAL_TRIALS study record update · 2021-01-14Biomarkers in First Episode Schizophrenia